Abstract
Glaucoma is a common blinding disease. Many of the currently available hypotonating eye drops are associated with adverse effects, such as ocular surface damage, which sometimes lead to discontinuation of treatment. We report the case of a 60-year-old man with glaucoma under hypotonizing treatment and unbalanced diabetes with diabetic retinopathy and diabetic peripheral neuropathy. The patient presented a severe damage of the ocular surface most probably shared between two components; the antiglaucoma treatment and their conservative on the one hand and the badly balanced diabetes with neuropathy on the other hand.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
